News from harmony biosciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 17, 2020, 08:05 ET Harmony Biosciences To Be Added To Russell 2000® And Russell 3000® Indexes

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Dec 15, 2020, 08:05 ET Harmony Biosciences Enrolls First Patient In Phase 2 Trial Evaluating Pitolisant For Excessive Daytime Sleepiness In Patients With Prader-Willi Syndrome

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Nov 11, 2020, 17:00 ET Harmony Biosciences Appoints Mark Graf And Eric Motley To Its Board Of Directors

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Oct 28, 2020, 08:05 ET Harmony Biosciences Announces Date Of Third Quarter 2020 Financial Results

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Oct 14, 2020, 08:05 ET Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX® (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Sep 22, 2020, 08:05 ET Harmony Biosciences Announces Recipients Of 2020 Patients At The Heart Grant On Second Annual World Narcolepsy Day

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Aug 28, 2020, 08:05 ET Harmony Biosciences Presents Efficacy And Safety Analyses For WAKIX® (pitolisant) At Virtual SLEEP 2020

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Aug 24, 2020, 08:05 ET Harmony Biosciences To Present New Data For WAKIX® (pitolisant) At SLEEP 2020 Annual Meeting

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...


Aug 21, 2020, 16:05 ET Harmony Biosciences Announces Closing Of Its Upsized Initial Public Offering And Exercise In Full Of Underwriters' Option To Purchase Additional Shares

Harmony Biosciences Holdings, Inc. ("Harmony"), a pharmaceutical company dedicated to developing and commercializing innovative therapies for...


Aug 18, 2020, 21:10 ET Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering

Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living...


Jul 30, 2020, 08:05 ET Harmony Biosciences Receives Patient Impact Award From Life Sciences Pennsylvania

Harmony Biosciences ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people...


Jun 02, 2020, 08:05 ET WAKIX® (pitolisant) Data From Harmony Biosciences Included on American Academy of Neurology Science Highlights Virtual Platform

Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people ...


Apr 29, 2020, 08:05 ET Harmony Biosciences Recognized By Fortune As A Top Ten 2020 Best Workplace In Biopharma

Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people ...


Apr 27, 2020, 08:05 ET Harmony Biosciences Expands Patients At The Heart Grant Program And Reinforces Its Commitment To Newly Uninsured Patients

Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing new treatment options for people...


Mar 30, 2020, 08:05 ET Harmony Biosciences Highlights Publication Of Narcolepsy Treatment Scientific Review In Sleep Medicine

Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people ...


Feb 03, 2020, 08:05 ET Harmony Biosciences Certified As A Great Place To Work In An Independent Survey

Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people ...


Jan 27, 2020, 08:00 ET Harmony Biosciences Secures $200 Million Debt Facility

Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people ...